×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AKRO – akero therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AKRO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/18
10:00 am
akro
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Akero Therapeutics, Inc. (AKRO) And Encourages Stockholders to Reach Out
Low
Report
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Akero Therapeutics, Inc. (AKRO) And Encourages Stockholders to Reach Out
12/15
10:00 am
akro
Bronstein, Gewirtz & Grossman, LLC Is Investigating Akero Therapeutics, Inc. (AKRO) And Encourages Stockholders to Connect
Low
Report
Bronstein, Gewirtz & Grossman, LLC Is Investigating Akero Therapeutics, Inc. (AKRO) And Encourages Stockholders to Connect
12/11
02:00 pm
akro
Akero Therapeutics, Inc. (AKRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
Low
Report
Akero Therapeutics, Inc. (AKRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
12/4
01:07 pm
akro
Why Is Akero Therapeutics, Inc. (AKRO) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? [Yahoo! Finance]
Low
Report
Why Is Akero Therapeutics, Inc. (AKRO) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? [Yahoo! Finance]
11/26
07:05 am
akro
Akero Therapeutics to Present at the 7th Annual Evercore ISI HealthCONx Conference [Yahoo! Finance]
Low
Report
Akero Therapeutics to Present at the 7th Annual Evercore ISI HealthCONx Conference [Yahoo! Finance]
11/26
07:00 am
akro
Akero Therapeutics to Present at the 7th Annual Evercore ISI HealthCONx Conference
Low
Report
Akero Therapeutics to Present at the 7th Annual Evercore ISI HealthCONx Conference
11/18
08:07 am
akro
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Medium
Report
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
11/18
07:28 am
akro
Akero Therapeutics, Inc. (NASDAQ: AKRO) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $65.00 price target on the stock.
Medium
Report
Akero Therapeutics, Inc. (NASDAQ: AKRO) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $65.00 price target on the stock.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/18
09:09 pm
akro
Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Young Jonathan
Low
Report
Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Young Jonathan
12/18
09:04 pm
akro
Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Lamy Patrick
Low
Report
Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Lamy Patrick
12/18
09:02 pm
akro
Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Yale Catriona
Low
Report
Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Yale Catriona
12/18
08:59 pm
akro
Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: White William Richard
Low
Report
Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: White William Richard
12/18
08:57 pm
akro
Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Gangloff Scott A.
Low
Report
Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Gangloff Scott A.
12/18
08:53 pm
akro
Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Rolph Timothy
Low
Report
Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Rolph Timothy
12/18
08:51 pm
akro
Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Cheng Andrew
Low
Report
Form 4 Akero Therapeutics, Inc. For: Dec 16 Filed by: Cheng Andrew
12/16
04:30 pm
akro
Form 144 Akero Therapeutics, Inc. Filed by: Lamy Patrick
Medium
Report
Form 144 Akero Therapeutics, Inc. Filed by: Lamy Patrick
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/30
Akero Therapeutics to Announce Results for Week 12 Efficacy Endpoints from NASH Phase 2a BALANCED Study of AKR-001
23.4%
4/9 Akero Therapeutics (NASDAQ: AKRO) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 15.2%
3/16 Form 10-K Akero Therapeutics, Inc. For: Dec 31 14.7%
6/19 Form 3 Akero Therapeutics, Inc. For: Jun 19 Filed by: Cheng Andrew 13.4%
4/24 Akero Therapeutics (NASDAQ: AKRO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $22.00 price target on the stock. 13.1%
6/25 Form 4 Akero Therapeutics, Inc. For: Jun 24 Filed by: Harrison Seth Loring 9.7%
12/19 Form 4 Akero Therapeutics, Inc. For: Dec 17 Filed by: Atlas Venture Fund XI, L.P. 7.6%
6/20 Form 424B4 Akero Therapeutics, Inc. 7.5%
4/13 Akero Therapeutics (NASDAQ: AKRO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 6.5%
4/7 Akero Therapeutics (NASDAQ: AKRO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 5.9%
4/9 Akero Therapeutics (NASDAQ: AKRO) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 15.2%
3/16 Form 10-K Akero Therapeutics, Inc. For: Dec 31 14.7%
6/19 Form 3 Akero Therapeutics, Inc. For: Jun 19 Filed by: Cheng Andrew 13.4%
4/24 Akero Therapeutics (NASDAQ: AKRO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $22.00 price target on the stock. 13.1%
6/25 Form 4 Akero Therapeutics, Inc. For: Jun 24 Filed by: Harrison Seth Loring 9.7%
12/19 Form 4 Akero Therapeutics, Inc. For: Dec 17 Filed by: Atlas Venture Fund XI, L.P. 7.6%
6/20 Form 424B4 Akero Therapeutics, Inc. 7.5%
4/13 Akero Therapeutics (NASDAQ: AKRO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 6.5%
4/7 Akero Therapeutics (NASDAQ: AKRO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 5.9%
TOP News Decliners
3/16
Q4/2019 12/31/2019 EPS -0.550 ZacksConsensus -0.580 ActVsEst 0.030 - Beat
-31.4%
1/21 Form 4 Akero Therapeutics, Inc. For: Jan 16 Filed by: Versant Venture Capital VI, L.P. -17.4%
3/18 Akero Therapeutics (NASDAQ: AKRO) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. -14.8%
9/6 Form 8-K Akero Therapeutics, Inc. For: Sep 05 -13.8%
3/6 Form 4 Akero Therapeutics, Inc. For: Mar 04 Filed by: Adelman Robert J -9.7%
12/31 Form 4 Akero Therapeutics, Inc. For: Dec 27 Filed by: Versant Venture Capital VI, L.P. -9.5%
1/2 Form 4 Akero Therapeutics, Inc. For: Dec 31 Filed by: Atlas Venture Fund XI, L.P. -8.7%
3/31 Form 8-K Akero Therapeutics, Inc. For: Mar 31 -7.8%
12/13 Form 4 Akero Therapeutics, Inc. For: Dec 13 Filed by: Rolph Timothy -7.8%
1/14 Form 4 Akero Therapeutics, Inc. For: Jan 13 Filed by: Adelman Robert J -6.0%
1/21 Form 4 Akero Therapeutics, Inc. For: Jan 16 Filed by: Versant Venture Capital VI, L.P. -17.4%
3/18 Akero Therapeutics (NASDAQ: AKRO) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. -14.8%
9/6 Form 8-K Akero Therapeutics, Inc. For: Sep 05 -13.8%
3/6 Form 4 Akero Therapeutics, Inc. For: Mar 04 Filed by: Adelman Robert J -9.7%
12/31 Form 4 Akero Therapeutics, Inc. For: Dec 27 Filed by: Versant Venture Capital VI, L.P. -9.5%
1/2 Form 4 Akero Therapeutics, Inc. For: Dec 31 Filed by: Atlas Venture Fund XI, L.P. -8.7%
3/31 Form 8-K Akero Therapeutics, Inc. For: Mar 31 -7.8%
12/13 Form 4 Akero Therapeutics, Inc. For: Dec 13 Filed by: Rolph Timothy -7.8%
1/14 Form 4 Akero Therapeutics, Inc. For: Jan 13 Filed by: Adelman Robert J -6.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: